Deal king: How Séamus Mulligan sold his pharma firm for $635m in five years

Deal king: How Séamus Mulligan sold his pharma firm for $635m in five years
Séamus Mulligan and his colleagues have just sold Narcan for $635 million

The lessons of Elan continue to yield rich rewards for the Irish pharma sector

In his autobiography, the leading Irish American entrepreneur Don Panoz names Séamus Mulligan as one of the key people who helped him turn a small firm in Athlone into a pharmaceutical powerhouse that was listed in Dublin, London and New York.

Please Subscribe or Log in to continue reading

Subscribe Login

Independent journalism every day

With digital access you can read The Business Post whenever, wherever, and however you want.

  • Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
  • Breaking news, comment and analysis from the best Business Post writers seven days a week.
  • Live blogs of major news events
  • Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
  • Access to The Business Post's extensive archive​

Related Articles

More from The Business Post